IM Therapeutics
www.imtherapeutics.comIM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
Read more
IM Therapeutics is building an HLA-directed platform for new therapies. We have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.
Read more
Country
State
Massachusetts
City (Headquarters)
Woburn
Industry
Employees
1-10
Founded
2015
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Immunology
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Chief Financial Officer and Chief Operations Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(14)
Reach decision makers at IM Therapeutics
Free credits every month!
IM Therapeutics FAQ
Woburn, United States
Pharmaceutical Manufacturing
